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Abstract
Background: General Practitioners (GPs) often report using clinical judgement to diagnose dementia. Aim: Investigate 
the accuracy of GPs’ clinical judgement for the diagnosis of dementia. Design and Setting: Diagnostic test accuracy 
study, recruiting from 21 practices around Bristol. Method: The clinical judgement of the treating GP (index test) was 
based on the information immediately available at their initial consultation with a person aged over 70 years who 
had cognitive symptoms. The reference standard was an assessment by a specialist clinician, based on a standardised 
clinical examination and made according to ICD-10 criteria for dementia. Results: 240 people were recruited, with a 
median age of 80 years (IQR 75 to 84 years), of whom 126 (53%) were men and 132 (55%) had dementia. The median 
duration of symptoms was 24 months (IQR 12 to 36 months) and the median ACE-III score was 75 (IQR 65 to 87). GP 
clinical judgement had sensitivity 56% (95% CI 47% to 65%) and specificity 89% (95% CI 81% to 94%). Positive 
likelihood ratio was higher in people aged 70-79 years (6.5, 95% CI 2.9 to 15) compared to people aged ≥ 80 years 
(3.6, 95% CI 1.7 to 7.6), and in women (10.4, 95% CI 3.4 to 31.7) compared to men (3.2, 95% CI 1.7 to 6.2), whereas 
the negative likelihood ratio was similar in all groups. Conclusion: A GP clinical judgement of dementia is specific, but 
confirmatory testing is needed to exclude dementia in symptomatic people who GPs judge as not having dementia.
Dementia | General Practice | Sensitivity and Specificity | Medical History Taking | Symptom Assessment
Correspondence: sam.creavin@bristol.ac.uk
How this fits in 
Previous studies in this area have investigated the accuracy of GP clinical judgement as a screening test for 
dementia in unselected people attending a primary care clinic or as a retrospective test based on their knowledge 
of their patient.  Some have derived the accuracy of judgement from the medical records, which may not reflect the 
judgement of the clinician. The role of the GP in supporting a more effective route to diagnosis for people with 
dementia is a research priority for patients, carers and clinicians. This study shows that, in a symptomatic older 
adult, clinical judgement may be useful for helping to confirm a diagnosis of dementia, whereas GP judgement 
should not by itself be used to exclude dementia.
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Introduction
The James Lind Alliance has identified the role of general practice in supporting a more effective route to diagnosis 
of dementia as a priority for health research (1). People with symptoms of dementia have historically faced long 
delays to get an assessment and an explanation for their symptoms (2). Approaches to address waiting lists have 
included psychiatrists supporting primary care memory clinics (3), integrated one-stop clinics (4), and training GPs 
to make a diagnosis in uncomplicated cases (5,6) which is supported by NICE (7). Some GPs have in the past been 
hesitant about diagnosing dementia when there is no disease modifying treatment (8) and disclosure of a diagnosis 
can still be problematic, especially if the affected person is not seeking help (9).  The situation has been complicated 
in the UK by controversial policies that have funded case-finding for dementia (10–12). Formally evaluating cognition 
takes time, and familiarity with tests.  A GP could use a range of brief cognitive assessments (13) to evaluate a person 
with symptoms of dementia and national guidelines differ on which test to use (14,15). Instead, GPs report using 
non-standardised processes (16), such as clinical judgement (17) to diagnose dementia. The sensitivity of GP clinical 
judgement for diagnosing dementia has been reported between from 51% (18) to 100% (19), and the specificity 
ranges from 58% (20) to 100% (19). 
Previous studies to investigate the accuracy of GP clinical judgement have typically suffered from one of two 
significant limitations (21). Firstly, a definition of clinical judgement which is of unclear relevance to practice, such 
as judgement in hindsight, or documentation of recorded diagnoses in the medical record which are systematically 
incomplete (22). Secondly, sampling unselected people attending general practice regardless of symptoms, which is 
more akin to screening. The aim of this study was to address these limitations of earlier studies and investigate the 
prospective diagnostic accuracy of GP clinical judgement for the diagnosis of dementia syndrome in symptomatic 
people over 70 years  (23).
Methods.
Population. 
We recruited participants from 21 participating GP surgeries in the Bristol, North Somerset, and South 
Gloucestershire (BNSSG) area, which is a diverse geographic area within 15 miles of the City of Bristol, covering a 
total population of around 900,000 people across 82 GP practices. Research clinics were in four participating GP 
surgeries, strategically located for accessibility. We calculated that a minimum sample size of 200 was needed, based 
on a specificity of 95% in prior studies, and a 75% prevalence of dementia in local memory clinic data (24).
Inclusion and exclusion criteria. 
Participants were people with cognitive symptoms but no prior diagnosis of dementia, aged at least 70 years and had 
been referred by their GP to this research study. Cognitive symptoms were not specified but generally include 
disturbance in memory, language, executive function, behaviour, and visuospatial skills (25). Symptoms were 
required to be present for at least six months, and could be reported by the person themselves, a family member, a 
professional, or another person; there was no severity threshold. Cognitive problems did not need to be the focus of 
the consultation and (as routine practice) GPs could enquire about cognition if they perceived a problem. Symptom 
duration was determined from the clinical history. An accompanying informant was mandatory. All participants were 
offered free accessible transport and translation services. People were excluded if they had a known neurological 
disorder (i.e. Parkinsonism, Multiple Sclerosis, learning disability, Huntington’s disease), registered blind, profound 
deafness (i.e. unable to use a telephone), psychiatric disorder requiring current secondary care input, or if cognitive 
symptoms were either rapidly progressive or co-incident with neurological disturbance. People with cognitive 
problems that were so advanced that they were unable to consent were excluded as they were judged by a lay 
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advisory group to find the research process overly burdensome. GPs were encouraged to make a clinical judgement 
and refer a consecutive series of all eligible patients with cognitive symptoms to the study, regardless of what their 
clinical judgement was or any test results. GPs gave study information including a leaflet, and obtained verbal consent 
to share contact details with the study on a referral form, including the persons age, sex, contact details, and the GPs 
clinical judgement. The study team contacted people referred by GPs to re-confirm eligibility, provide further written 
study details, and offer a research clinic appointment. The research team took written consent from all participants.
Index test of clinical judgement. 
The referring GP recorded their clinical judgement using an electronic referral form during a consultation with their 
patient about cognitive symptoms. Clinical judgement was operationalised as normal, cognitive impairment not 
dementia (CIND), or dementia as options for response to the question "Is your gut feeling that this person has..". GPs 
were not specially trained, were not required to arrange any test, and could refer people simultaneously or 
subsequently to NHS services. The study team contacted the practice at least three times to obtain any missing 
referral data.
Reference standard. 
At the research clinic, a single specialist physician conducted a standardised assessment lasting approximately 60 
minutes comprising clinical history, the Addenbrooke’s Cognitive Examination III (ACE-III) (26), Brief Assessment 
Schedule Depression Cards (BASDEC) (27) and the informant-completed Bristol Activities of Daily Living (BADL) 
Questionnaire (28). The specialist was not aware of other test results including GP judgement or investigations. The 
reference standard was based on the evaluation of the specialist physician for dementia according to ICD-10 criteria 
(29) for each individual patient; specific cut-offs on the aforementioned measures were not used and the expert 
used her integrated assessment to reach a diagnosis. Cognitive impairment not dementia (CIND), was diagnosed by 
the same expert and included Petersen MCI (30) and other causes of cognitive impairment that met neither criteria 
for ICD-10 dementia nor Petersen MCI, such as traumatic brain injury or affective disorder. Medical records were 
reviewed for all participants six months after the research clinic to identify any subsequent information that would 
contradict this judgement. A second specialist adjudicated cases where there was diagnostic uncertainty at the 
research clinic using the initial specialist assessment and the medical record review, but without access to GP 
judgement. Study data were electronically entered and managed using REDCap (Research Electronic Data Capture) 
hosted at the University of Bristol (31). 
Statistical methods. 
Separate logistic regression analyses were used with non-participation (referred by GP but not taking part) as the 
dependent variable and GP judgement, age (in years) and female sex as the independent variables to test the 
hypothesis of no association with these variables. Time from referral to appointment was described using median 
and interquartile range and logistic regression was used to test the hypothesis of no association between time to 
appointment (in days) and dementia (as the dependent variable). Measures of diagnostic test accuracy were 
calculated together with 95% confidence intervals, for GP judgement of dementia against reference standard of 
dementia. Sensitivity analyses were done to explore whether accuracy varied by age (<80 years | ≥ 80 years) since 
prediction models perform differently in these age groups (32), and sex. Cochran’s Q test was used to test the 
hypothesis of no difference in likelihood ratios between groups (33). We report this diagnostic test accuracy study in 
line with STARDdem guidelines.
                               
                             




Figure 1 goes here caption: STARDdem flowchart for inclusion of participants in the study
Recruitment took place between March 2015 and May 2017. Figure 1 shows a flowchart for inclusion in the study. 
The theoretically “eligible” figure of 1,735 people was derived from the age specific incidence of dementia (34) and 
the demographics of the population in the participating practices (34,956 aged over 70 years (35)). The number 
approached is unknown. One person who consented withdrew before any data were collected because they were 
acutely ill. Of the 240 with available data, there were 20 borderline cases that were adjudicated by a second specialist. 
The 240 people were classified by the reference standard as either Normal (47), Dementia (132) of whom 1 had DSM-
5 but not ICD-10 because they had subjective but not objective amnesia, or were CIND (61) of 59 whom met criteria 
for MCI (1 affective disorder, 1 brain injury). Compared to people who participated, there was little evidence of an 
association between non-participation and a GP clinical judgement of CIND (odds ratio 1.2; 95% CI 0.55 to 2.41) or 
dementia (odds ratio 1.9; 95% CI 0.90 to 3.93). Compared to people who participated, non-participants were older 
(odds ratio per year 1.08; 95% CI 1.04 to 1.12), or more often female (odds ratio 1.88; 95% CI 1.21 to 2.92). The 
median time between referral (clinical judgement) and the clinic appointment (reference standard) was 47 days (IQR 
30 to 72 days), the longest interval was 177 days, due to difficulties attending earlier appointments. There was no 
association between time from referral to appointment and dementia (odds ratio per day 1.0; 95% CI 0.99 to 1.01). 
Table 1 shows the demographics of participants and shows a cross tabulation of GP opinion against the reference 
standard, allowing derivation of diagnostic accuracy of clinical judgement for both CIND and dementia.
Table 1 goes here
Two people could not complete the ACE-III because English was not their first language; they had both declined an 
interpreter. In both cases sufficient information was available from other parts of the assessment for a categorisation 
about cognition to be made (one had normal cognition, one had dementia). For the 238 people who had an ACE-III 
score, the median was 75 (interquartile range 65 to 87). Referring GPs judged that 34 people were normal, 86 had 
dementia, and 120 were CIND; the one person who withdrew from the study due to acute illness was judged by the 
referring GP to have CIND. People that GPs judged as having dementia had a total ACE-III score IQR of 60 to 74, with 
a 90th centile of 81/100 and highest score of 95/100. Similarly, people that GPs judged as having CIND had an ACE-III 
score IQR 71 to 89.
Diagnostic accuracy. 
Table 2 goes here
Table 2 shows the diagnostic accuracy for GP judgement for dementia. The sensitivity and specificity of GP 
judgement were respectively 56% (95% CI 47% to 65%) and 89% (95% CI 81% to 94%). Clinical judgement was more 
useful for ruling in dementia, than ruling it out, with higher specificity and positive predictive value than sensitivity 
and negative predictive value. In people aged 80 or more years, clinical judgement had similar sensitivity (p=0.296) 
and specificity (p=0.798) to those aged under 80 years. There was weak evidence that clinical judgement in women 
had a higher specificity (p=0.074) and a higher sensitivity (p=0.064) than clinical judgement in men.
Discussion
Summary. 
From 21 participating GP surgeries, 456 people were referred and 240 were evaluated. Of these, 132 (55%; 95% CI 
48% to 61%) had dementia. Clinical judgement as a single test had a LRP of 5 (95% CI 3 to 9) and a LRN of 0.5 (95% 
CI 0.4 to 0.6) for the target condition dementia. People that GPs judged as having dementia had a total ACE-III score 
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IQR of 60 to 74, and those that they judged as having MCI had a total ACE-III IQR 71 to 89. This compares to published 
ACE-III thresholds of <82 for dementia (36) and <88 for MCI (36) and suggests that in this study GPs are not being 
overly restrictive in their judgement for dementia, or liberal in their judgement for CIND.
Strengths and limitations. 
The patient selection in the current study closely reflects real world clinical practice in the United Kingdom, with 
efforts to avoid exclusion based on language, transport, or appointment availability. Participants were included with 
a range of GP opinions about the presence of cognitive impairment in people who had presented with symptoms in 
a consultation; typically 2.5 problems are discussed per appointment (37). The index test reflects an average 
measure of diagnostic accuracy for an estimated 142 whole time equivalent GPs working in different settings (38), 
who were not specially trained. We instructed GPs not to use any formal test to inform their judgement, but it is 
possible that brief cognitive tests such as GP Cog (39) may have been occasionally used. Based on previous studies, 
clinical judgement is likely to be based on rules of thumb (16), not formal tests (17), and information on referral 
forms indicated that judgement was informed by "face to face presentation". The interval between clinical 
judgement and the reference standard was unlikely to be associated with a significant progression in cognitive 
impairment (15). We fully verified the index test for all consenting participants, obtained follow-up data after six 
months, and adjudicated uncertain cases. 
There was no evidence of selective participation by cognitive status, but non-participants may differ in other 
unmeasured ways which affect diagnostic accuracy. As reported in the Results we estimate that up to 1,735 people 
in the study population would have developed symptoms in the study period, but it is unknown how many of these 
would have presented to their GP. We have no data on recruitment bias, but dementia was less prevalent than we 
predicted based on local memory clinic data, suggesting a lower threshold for referral to the study. Any systematic 
selection bias in who GPs referred to the study (such as excluding more frail people) would limit the generalisability 
of our findings to that group. An important limitation is that despite providing translation services the population 
were largely white, native English speakers. In addition, the confidence intervals for our sub-groups are still wide. 
We excluded people with advanced cognitive impairment that could not consent, so our findings cannot be 
generalised to that group; though it is likely that GPs would be more sensitive in identifying cognitive impairment at 
a more advanced stage. 
Comparison with existing literature. 
Table 3 goes here 
Table 3 summarises the features of this study compared to the existing literature (40,41). A major strength of this 
study for applicability to practice is that it is one of only two studies to evaluate symptomatic people. Our study has 
the smallest number undergoing the index test, but only one other study has complete verification by the reference 
standard (42). Our study has lower sensitivity and higher specificity than the French study (20), but this could be 
because the French study verified only 26% of people who underwent the index test (where participating GPs referred 
five patients per GP over two years), or because other studies did not require participants to be symptomatic and 
consequently had a lower prevalence of dementia (ranging 2% to 29%) (43–46). 
Implications for Research and/or practice. 
The accuracy of clinical judgement was comparable to other brief cognitive tests, many of which are now subject to 
licensing restrictions. The test characteristics of clinical judgement would support an approach to subsequent testing 
where highly sensitive tests are performed in people who GPs judge as not having dementia but there is significant 
patient concern (to rule out disease), and very highly specific, but minimally burdensome tests are done in people 
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who GPs do think have dementia. This would be a change to current practice where cognitive testing is typically done 
with the same tests regardless of GP judgement. 
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Figure 1.  STARDdem flowchart for inclusion of participants in the study 
                               
                             
                     
Table 1. Characteristics of participants by cognitive category
Cognitive category ∗
Characteristic Dementia CIND Normal
n=132 n=61 n=47
Sex n (column %)
Male 68 (52) 35 (57) 23 (49)
Female 64 (49) 26 (43) 24 (51)
Age (years) Median (IQR)
At clinic 82 (77-86) 80 (75-83) 75 (72-80)
Left school 15 (15-16) 15 (15-16) 16 (15-16)
Retired 60 (58-65) 60 (58-67) 61 (58-65)
Symptom onset
Median (IQR) (months)
Time ago 24 (12-36) 18 (12-24) 21 (12-36)
Type, n (column %)
Gradual 111 (84) 55 (90) 43 (91)
Sudden 13 (10) 5 (8) 0 (-)
Uncertain 8 (6) 1 (1) 4 (9)
Symptom pattern n (column %)
Course
Progressive 111 (84) 42 (69) 29 (62)
Stepwise 2 (2) 0 (-) 0 (-)
Regressive 1 (1) 1 (2) 1 (2)
Static 5 (4) 7 (11) 9 (19)
Uncertain 13 (10) 11 (18) 8 (17)
Fluctuation
None 112 (85) 53 (87) 45 (96)
Within one day 12 (9) 5 (8) 1 (2)
Over several days 8 (6) 3 (5) 1 (2)
ACE-III Score median (IQR)
Total (max 100) 69 (61-74) 82 (76-87) 93 (90-95)
GP opinion n (row %)
Normal 6 (18) 9 (26) 19 (56)
CIND 52 (43) 41 (34) 27 (23)
Dementia 74 (86) 11 (13) 1 (1)
Dementia according to ICD-10 definition; MCI according to Petersen definition.
ACE-III Addenbrookes’ Cognitive Examination III; CIND Cognitive impairment, not dementia.
                               
                             
                     
Table 3. Summary of seven studies investigating GP judgement for the diagnosis of dementia
Mannheim Sydney Hawaii Antwerp AgeCoDe France This study
(43) (44) (42) (45)
Participant selection*
(46) (20)
Series C C C C R C C
Symptomatic No No** No No
Characteristics of participants
No Yes** Yes
Number (index test) 3721 433 303 1003 3242 1453 240
Mean age (years) 76 85 75 75 80 81 80
% Female 70 84 63 63 66 71 47
% with dementia 29 25 9 2
Target condition and verification with reference standard
2 50 55
Verified N 407 105 303 101 22 385 240
Verified % 11 24 100 1
GP Judgement (%)
70 26 100
Not impaired 36 76 33 - 94 48 14
Cognitive impairment 41 - - - - - 40
Dementia 23 19 33 - 6 26 36
Uncertain - 5 33 -
Diagnostic accuracy of clinical judgement for dementia
- 22 -
Sensitivity 91 42 - 100 51 73 56
Specificity 76 89 - 100 96 58 89
C Consecutive R Random Symptomatic: symptoms required for 
participation % verified = number underwent reference test / 
number underwent index test % with dementia = number with 
dementia / number verified
** Participants were not presenting with symptoms but GPs were asked to maximise the inclusion 
of people with suspected dementia – not reported
                               
                             
                     
Table 2. Accuracy of GP judgement for the diagnosis of dementia
Sensitivity Specificity PPV NPV LRP LRN
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
GP judgement 56 (47 to 65) 89 (81 to 94) 86 (77 to 93) 62 (54 to 70) 5.1 (2.9 to 8.8) 0.49 (0.40 to 0.61)
(n=240)
Age ≥ 80 years 57 (45 to 67) 84 (67 to 94) 89 (77 to 96) 46 (34 to 59) 3.6 (1.7 to 7.6) 0.52 (0.39 to 0.68)
(n=123)
Age < 80 years 55 (40 to 70) 91 (82 to 97) 81 (64 to 93) 75 (65 to 84) 6.5 (2.9 to 15) 0.49 (0.35 to 0.68)
(n=117)




63 (50 to 74) 94 (84 to 99) 93 (81 to 99) 66 (54 to 77) 10.4 (3.4 to 31.7) 0.40 (0.29 to 0.55)
LRN negative likelihood ratio LRP positive likelihood ratio NPV 
